Promising mode of action and appears safe but from my reading there is no proof of concept as far as patient benefit. This would be Bourne out of Ph3 trials. Anyone?
Ann: Positive Results from CSL112 Phase 2b Trial, page-5
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$308.53 |
Change
3.060(1.00%) |
Mkt cap ! $149.0B | |||
| Open | High | Low | Value | Volume |
| $308.99 | $308.99 | $305.97 | $232.7M | 769.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 913 | $307.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $308.59 | 20 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| CSL (ASX) Chart |